[1] 《中国心血管健康与疾病报告2021》要点解读[J].中国心血管杂志,2022,27(4):305-318.
[2] DING X, YANG Z. Knowledge mapping of platform research: a visual analysis using VOSviewer and CiteSpace. Electron Commer Res. 2020: 1-23.
[3] 华薇娜,施云,岳泉.美国ISI公司网络版引文索引数据库评价[J].情报理论与实践,2001(1):49-51+55.
[4] PAN X, YAN E, CUI M, et al. Examining the usage, citation, and diffusion patterns of bibliometric mapping software: A comparative study of three tools. J Informetr. 2018;12(2):481-493.
[5] 陈悦,陈超美,刘则渊,等.CiteSpace知识图谱的方法论功能[J].科学学研究,2015,33(2):242-253.
[6] 付健,丁敬达.Citespace和VOSviewer软件的可视化原理比较[J].农业图书情报,2019,31(10):31-37.
[7] 万晓霞.用文献计量法分析我国中医痹证研究的现状及发展趋势[J].医学情报工作,2000(6):9-10.
[8] PRICE DS. A general theory of bibliometric and other cumulative advantage processes. J Am Soc Inf Sci. 1976;27(5):292-306.
[9] HAUSENLOY DJ. Cardioprotection techniques: preconditioning, postconditioning and remote con-ditioning (basic science). Curr Pharm Des. 2013;19(25):4544-4563.
[10] MADONNA R, VAN LAAKE LW, DAVIDSON SM, et al. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J. 2016;37(23):1789-1798.
[11] CHEN J, ZHAN Y, WANG Y, et al. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats. Acta Biomater. 2018;80: 154-168.
[12] YANG Y, SUN Y, YI W, et al. A review of melatonin as a suitable antioxidant against myocardial ischemia–reperfusion injury and clinical heart diseases. J Pineal Res. 2014;57(4):357-366.
[13] 倪清蓉,洪环宇,孔静,等.间充质干细胞与缺血性心脏病[J].中国体外循环杂志,2016,14(2):125-128.
[14] ONG SB, HERNANDEZ-RESENDIZ S, CRESPO-AVILAN GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol ther. 2018;186:73-87.
[15] WAHID A, MANEK N, NICHOLS M, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta‐analysis. J Am Heart Assoc. 2016;5(9): e002495.
[16] HAUSENLOY DJ, KHARBANDN RK, MøLLER UK, et al. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet. 2019;394(10207):1415-1424.
[17] ANDREADOU I, CABRERA-FUENTES HA, DEVAUX Y, et al. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res. 2019;115(7):1117-1130.
[18] SARASWATI S, ALFARO MP, THORNE CA, et al. Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PloS one. 2010;5(11):e15521.
[19] GAEBEL R, FURLAIN D, SORG H, et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. Plos one. 2011, 6(2): e15652.
[20] 吴卓晶,刘君,王应宽.Nature、Science及PLoS ONE网络出版现状分析[J].中国科技期刊研究,2014,25(1):44-48.
[21] MOLITOR M, RUDI W S, GARLAPATI V, et al. Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1. Cardiovasc Res. 2021, 117(1): 162-177.
[22] TAO Z, LOO S, SU L, et al. Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.Cardiovasc Res. 2021;117(6):1578-1591.
[23] GARIKIPATI VNS, VERMA SK, JOLARDARASHI D, et al. Therapeutic inhibition of miR-375 attenuates post-myocardial infarction inflammatory response and left ventricular dysfunction via PDK-1-AKT signalling axis. Cardiovasc Res. 2017;113(8):938-949.
[24] ZHU LP, TIAN T, WANG JY, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018;8(22):6163.
[25] GAO L, GREGORICH ZR, ZHU W, et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell–derived cardiac cells improve recovery from myocardial infarction in swine. Circulation. 2018;137(16):1712-1730.
[26] EGUCHI S, TAKEFUJI M, SAKAGUCHI T, et al. Cardiomyocytes capture stem cell-derived, anti-apoptotic microRNA-214 via clathrin-mediated endocytosis in acute myocardial infarction. J Biol Chem. 2019;294(31): 11665-11674.
[27] 胡缤予,徐韬,赵凌.近十年针灸治疗功能性消化不良研究的热点及趋势——基于文献关键词聚类分析[J].中医杂志,2022,63(14): 1327-1332.
[28] WANG NA, CHEN C, YANG D, et al. Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):2085-2092.
[29] ZHAO G, YU L, GAO W, et al. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress. Acta Pharmacol Sin. 2016;37(3):354-367.
[30] MOGHADDOM AS, AFSHARI JT, ESMAEILI SA, et al. Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease. Atherosclerosis. 2019;285:1-9.
[31] XIE M, KONG Y, TAN W, et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation. 2014;129(10):1139-1151.
[32] SCHULZ R, GöRGE PM, GöRBE A, et al. Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection. Pharmacol Ther. 2015;153:90-106.
[33] STUB D, SMITH K, BERNARD S, et al. Air versus oxygen in ST-segment–elevation myocardial infarction. Circulation. 2015;131(24):2143-2150.
[34] MIRIYALA S, SPASOJEVIC I, TOVMASYAN A, et al. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta Mol Basis Dis. 2012;1822(5):794-814.
[35] ZHANG F, SONG G, LI X, et al. Transplantation of iPSc ameliorates neural remodeling and reduces ventricular arrhythmias in a post‐infarcted swine model. J Cell Biochem Suppl. 2014;115(3):531-539.
[36] SHI H, GAO Y, DONG Z, et al. GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I/R injury. Circ Res. 2021;129(3):383-396.
[37] ZWETSLOOT PP, VEGH AMD, JANSEN OF LORKEERS SJ, et al. Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies.Circ Res. 2016;118(8):1223-1232.
[38] KHAN K, GASBARRINO K, MAHMOUD I, et al. Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models. Syst Rev. 2018;7(1):1-7.
[39] 尤宏钊,张健.干细胞治疗心肌梗死和缺血性心力衰竭的临床应用进展[J].中国循环杂志,2014,29(6):476-478.
[40] BOLLI R, CHUGH AR, D’AMARIO D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378(9806):1847-1857.
[41] ASSMUS B, WALTER DH, SEEGER FH, et al. Effect of shock wave–facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA. 2013; 309(15):1622-1631.
[42] 张晓霞,王晓曦,段海峰,等.脐带华通胶间充质干细胞治疗缺血性心脏病临床疗效观察[J].解放军医学院学报,2013,34(5):431-434.
[43] 褚玉茹,于乃浩,阚建英.骨髓来源干细胞移植治疗急性心肌梗死患者的临床疗效和安全性的Meta分析[J].天津医药,2018,46(9): 1005-1012.
[44] 罗志荣,蔡昊,王强利,等.临床应用干细胞治疗心肌梗死面临的问题及进展[J].转化医学电子杂志,2018,5(1):44-47.
[45] 张屿森,崔光辉,刘俐,等.干细胞治疗缺血性心肌病的临床研究进展[J].中华临床医师杂志(电子版),2019,13(1):65-68. |